HER2 Support Group Forums - View Single Post - Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in

News · 02-22-2016, 03:14 AM

Amgen and UCB today announced top-line results from the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME).

More...

02-22-2016, 03:14 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 20,133	Romosozumab for postmenopausal women with osteoporosis meets co-primary endpoints in Amgen and UCB today announced top-line results from the Phase 3 placebo-controlled FRActure study in postmenopausal woMen with ostEoporosis (FRAME). More...